Monday, October 31, 2011

Nowhere to Go

Is there nowhere to run on this globe from the baleful, sinister, and destructive power corporations hold over all our lives? No wonder there's a worldwide outbreak of visible protests against what they are doing to us. Listen, the "Occupy" movements that are happening everywhere are an encouraging sign. An indication that people are aware of what's happening to them. The pain that's being inflicted, the utter unfairness of what's being done to people all over the globe just so these monstrously rich companies can get even richer, can squeeze even more out of people who for over thirty years have been steadily bled by corporate and personal greed. I could probably blog every day on corporate malfeasance. It's a subject that never ends.

A case in point: I read that President Obama has ordered the FDA to "take actions to help reduce prescription drug shortages." Say what? Yes, that's correct. This year, in fact, shortages of over 200 of them have been reported--and this is near a record for this type of thing--involving cancer drugs, anesthetics for surgery patients, emergency medicines, electrolytes that patients need for IVs, and more. So what happens is treatment is delayed, surgeries postponed, or "make do with costlier and less-effective substitutes." Emphasis on costlier.

The FDA says many drugs in short supply are injectable, harder to manufacture, store, and ship. There are also supposedly manufacturing issues and raw materials shortages. Don't know about you, but this sounds like Big Pharma smoke. Why? Get this: "Companies may stop manufacturing older drugs in favor of newer, more profitable drugs, and the FDA can't require a firm to keep making a drug it wants to discontinue." What does that tell you? Tells me that generics are being discontinued along with the others that don't make as much profit.

The new executive order is not going to get at the root of the problem, which is unbridled greed. It's just going to require the FDA to urge drug manufacturers to voluntarily tell FDA about looming potential shortages so there will be earlier warnings. Oh, and the FDA is also going to monitor for price gouging. Monitor! Are you kidding me? Here's what the FDA spokesperson said about the current situation: "In recent months, we've heard reports of enormous markups such a blood pressure medicine usually priced at $26 being sold for $1,200." Do you think this is going to change with the FDA "monitoring"? This executive order is window dressing. Big Pharma is murdering us again. Bastards!

Post a Comment